Sign Up Now to Download a Free Research Report on
Sign-Up to Get the Equity Report on this Company Plus Exclusive Access to Our Winning Newsletter Alerts
Having problems viewing PDF files? Emergent Biosolutions, Inc.
Emergent Biosolutions shares spiked over 5 percent Wednesday after reporting that their treatment for chronic lymphocytic leukemia, TRU-016, received medicinal product designation from the European Commission.
Going forward ... (see research report)
Subscribe to News Feeds